China Universal Asset Management »

Vir Biotechnology shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $263k 26k 10.13
2023-12-31 $157k 16k 10.09
2023-09-30 $32k 3.4k 9.28
2023-06-30 $43k 1.8k 24.49
2023-03-31 $42k 1.8k 23.22
2022-12-31 $34k 1.4k 25.13
2022-09-30 $24k 1.2k 19.32

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Vir Biotechnology

Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Bill & Melinda Gates Foundation
Citigroup
Charles Schwab Investment Management
Bank of New York Mellon
D. E. Shaw & Co
Dimensional Fund Advisors
Goldman Sachs Group
Voloridge Investment Management
UBS Group
Principal Financial Group
Empowered Funds

View all funds holding Vir Biotechnology